全文获取类型
收费全文 | 1063篇 |
免费 | 94篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 58篇 |
妇产科学 | 8篇 |
基础医学 | 104篇 |
口腔科学 | 33篇 |
临床医学 | 192篇 |
内科学 | 242篇 |
皮肤病学 | 13篇 |
神经病学 | 39篇 |
特种医学 | 242篇 |
外科学 | 57篇 |
综合类 | 33篇 |
预防医学 | 54篇 |
眼科学 | 8篇 |
药学 | 39篇 |
中国医学 | 5篇 |
肿瘤学 | 34篇 |
出版年
2024年 | 2篇 |
2023年 | 8篇 |
2022年 | 3篇 |
2021年 | 17篇 |
2020年 | 12篇 |
2019年 | 8篇 |
2018年 | 24篇 |
2017年 | 14篇 |
2016年 | 21篇 |
2015年 | 26篇 |
2014年 | 30篇 |
2013年 | 33篇 |
2012年 | 24篇 |
2011年 | 41篇 |
2010年 | 39篇 |
2009年 | 57篇 |
2008年 | 38篇 |
2007年 | 12篇 |
2006年 | 15篇 |
2005年 | 7篇 |
2004年 | 10篇 |
2003年 | 21篇 |
2002年 | 11篇 |
2001年 | 18篇 |
2000年 | 18篇 |
1999年 | 17篇 |
1998年 | 51篇 |
1997年 | 52篇 |
1996年 | 65篇 |
1995年 | 49篇 |
1994年 | 45篇 |
1993年 | 50篇 |
1992年 | 20篇 |
1991年 | 13篇 |
1990年 | 18篇 |
1989年 | 37篇 |
1988年 | 32篇 |
1987年 | 34篇 |
1986年 | 33篇 |
1985年 | 24篇 |
1984年 | 17篇 |
1983年 | 10篇 |
1982年 | 22篇 |
1981年 | 14篇 |
1980年 | 8篇 |
1979年 | 2篇 |
1978年 | 4篇 |
1977年 | 12篇 |
1976年 | 12篇 |
1975年 | 13篇 |
排序方式: 共有1164条查询结果,搜索用时 31 毫秒
1.
Francois Rheault Alessandro De Benedictis Alessandro Daducci Chiara Maffei Chantal M. W. Tax David Romascano Eduardo Caverzasi Felix C. Morency Francesco Corrivetti Franco Pestilli Gabriel Girard Guillaume Theaud Ilyess Zemmoura Janice Hau Kelly Glavin Kesshi M. Jordan Kristofer Pomiecko Maxime Chamberland Muhamed Barakovic Nil Goyette Philippe Poulin Quentin Chenot Sandip S. Panesar Silvio Sarubbo Laurent Petit Maxime Descoteaux 《Human brain mapping》2020,41(7):1859-1874
Investigative studies of white matter (WM) brain structures using diffusion MRI (dMRI) tractography frequently require manual WM bundle segmentation, often called “virtual dissection.” Human errors and personal decisions make these manual segmentations hard to reproduce, which have not yet been quantified by the dMRI community. It is our opinion that if the field of dMRI tractography wants to be taken seriously as a widespread clinical tool, it is imperative to harmonize WM bundle segmentations and develop protocols aimed to be used in clinical settings. The EADC‐ADNI Harmonized Hippocampal Protocol achieved such standardization through a series of steps that must be reproduced for every WM bundle. This article is an observation of the problematic. A specific bundle segmentation protocol was used in order to provide a real‐life example, but the contribution of this article is to discuss the need for reproducibility and standardized protocol, as for any measurement tool. This study required the participation of 11 experts and 13 nonexperts in neuroanatomy and “virtual dissection” across various laboratories and hospitals. Intra‐rater agreement (Dice score) was approximately 0.77, while inter‐rater was approximately 0.65. The protocol provided to participants was not necessarily optimal, but its design mimics, in essence, what will be required in future protocols. Reporting tractometry results such as average fractional anisotropy, volume or streamline count of a particular bundle without a sufficient reproducibility score could make the analysis and interpretations more difficult. Coordinated efforts by the diffusion MRI tractography community are needed to quantify and account for reproducibility of WM bundle extraction protocols in this era of open and collaborative science. 相似文献
2.
3.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
4.
5.
6.
7.
8.
9.
10.